No Detail Found!

Immunohistochemical Expression of Epidermal Growth Factor Receptor and c-kit in Triple Negative Breast Cancer.

Author(s)
Rabia Ahmed Department of Histopathology, Armed Forces Institute of Pathology (AFIP), Rawalpindi, Pakistan
Hafeez Ud Din Department of Histopathology, Armed Forces Institute of Pathology (AFIP), Rawalpindi, Pakistan
Farhan Akhtar Department of Histopathology, PNS Shifa, Karachi, Pakistan
Saeed Afzal Department of Histopathology, Armed Forces Institute of Pathology (AFIP), Rawalpindi, Pakistan
Iqbal Muhammad Department of Histopathology, Armed Forces Institute of Pathology (AFIP), Rawalpindi, Pakistan
Shoaib Naiyar Hashmi Department of Histopathology, Armed Forces Institute of Pathology (AFIP), Rawalpindi, Pakistan
Abstract
Objective: To determine the frequency of immunohistochemical expression of epidermal growth factor receptor (EGFR) and c-KIT in triple negative breast cancer (TNBC). Study Design: Descriptive, cross-sectional study. Place and Duration of Study: Armed Forces Institute of Pathology (AFIP), Rawalpindi, from January to December 2014. Methodology: Fifty cases of triple negative breast cancer diagnosed on immunohistochemistry were included in the study. Patients' gender and age were noted. Immunohistochemistry for EGFR and c-KIT were applied and the results were recorded. The data were analyzed by using computer software programme SPSS version 19. Descriptive statistics, frequencies and percentages were calculated. Results: Out of 50 patients of TNBC, all patients were females. The ages of the patients ranged between 30 and 80 years with an average age of 48.9 years and standard deviation of ±10.0. Out of 50 cases, 29 cases (58%) were positive for EGFR while 15 cases (30%) were positive for c-KIT. Thirteen cases (26%) were positive for both EGFR and c-KIT. Nineteen cases (38%) were negative for both EGFR and c-KIT. Conclusion: EGFR expression was observed in 58% and c-KIT expression was seen in 30% of the cases. The results of EGFR expression are almost similar while those of c-KIT are different from international studies which suggest immunohistochemical differences between the studied populations.
Publication Details
Page(s) 570-572
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 26, Issue: 7, Year: 2016

Request the full text from PASTIC

Keywords
c-KIT. EGFR. Triple negative breast cancer
References
FormentiSC,ArslanAA,LoveSM, 2012.Global breast cancer: The lessons to bring home,Int J Breast Cancer 249501 -
ParveenS,SarwarG,KhuwajaM,AhmedR,NazeerM., 2011.Carcinoma of breast, pattern and presentation in developing countries,Pak J Surg 24 246 -9
OnitiloAA,EngelJM,GreenleeRT,MukeshBN, 2009.Breast cancer subtypes based on ER/PR and Her2 expression: Comparison of clinicopathologic features and survival,Clin Med Res 7 4 -13
SpitaleA,MazzolaP,SoldiniD,MazzucchelliL,BordoniA, 2009.Breast cancer classification according to immunohistochemical markers: Clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland,Ann Oncol 20 628 -35
PalaEE,BayolU,CumurcuS,KeskinE., 2012.Immunohistochemical characteristics of triple negative/basal-like breast cancer,Turk Patoloji Derg 28 238 -44
AkiyamaF,IwaseH, 2009.Triple negative breast cancer: Clinicopathological characteristics and treatment strategies,Breast Cancer 16 252 -3
SasakiY,Tsuda H, 2009.Clinicopathological characteristics of triplenegative breast cancers,Breast Cancer 16 254 -9
PengY., 2012.Potential prognostic tumor biomarkers in triplenegative breast carcinoma,Beijing Da Xue Xue Bao 44 666 -72
CheangMCU,VoducD,BajdikC,LeungS,McKinneyS,ChiaSK, 2008.Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype,Clin Cancer Res 14 1368 -76
RakhaEA,El-SayedME,GreenAR,LeeAHS,RobertsonJF,EllisIO, 2007.Prognostic markers in triple-negative breast cancer,Cancer 109 25 -32
FoleyJ,NickersonNK,NamS,AllenKT,GilmoreJL,NephewKP, 2010.EGFR signaling in breast cancer: Bad to the bone,Semin Cell Dev Biol 21 951 -60
ReganJL,KendrickH,MagnayF,VafaizadehV,GronerB,Smalley MJ, 2012.c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer,Oncogene 31 869 -83
CareyLA,RugoHS,MarcomPK,MayerEL,EstevaFJ,MaCX, 2008.EGFR inhibition with cetuximab added to carboplatin in metastatic triple-negative (basal-like) breast cancer,J Clin Oncol 26 1009 -
CorkeryB,CrownJ,ClynesM,O'DonovanN., 2009.Epidermal growth factor receptor as a potential therapeutic target in triplenegative breast cancer,Ann Oncol 20 862 -7
SartorC,ZhouH,PerouCM,EthierSP, 2004.Basal-like breast tumor-derived cell lines are growth inhibited and radiosensitized by epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,Breast Cancer Res Treat 88 311 -
KandulaM,ChennaboinaKK,YsAR, 2013.Molecular mechanism and targeted therapy options of triple-negative (ER, PgR,Cancer: Review. World J Oncol 4 137 -41
FinnRS,BengalaC,IbrahimN,RochéH,SparanoJ,StraussLC, 2011.Dasatinib as a single agent in triple-negative breast cancer: Results of an open-label phase 2 study,Clin Cancer Res 17 6905 -13
KanapathyP,TaySK,NairA,LeongCO, 2012.Triple-negative breast cancer is associated with EGFR, CK5/6 and c-KIT expression in Malaysian women,BMC Clin Pathol 12 18 -
Giraldo-JiménezMY,CabanillasF,NegrónV,EcheniqueM,MojicaP,SantiagoK,RHealth Sci,J, 2012.Triple negative breast cancer: A retrospective study of Hispanics residing in Puerto Rico, 31 45 -51
SajidMT,AhmedM,AzharM,MustafaQ,ShukarI,AhmedM, 2014.Age related frequency of triple negative breast cancer in women,J Coll Physicians Surg Pak 24 400 -3
LermaE,PeiroG,RamónT,FernandezS,MartinezD,PonsC, 2007.Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas),Mod Pathol 20 1200 -7
ChoccalingamC,RaoL,RoaS.,Cancer, 2012.Clinicopathological characteristics of triple negative and non triple negative high grade breast carcinomas with and without basal marker (CK5/6 and EGFR) expression at a rural tertiary hospital in India, 6 21 -9
ZhuY,WangY,GuanB,RaoQ,WangJ,MaH, 2014.C-kit and PDGFRA gene mutations in triple negative breast cancer,Int J Clin Exp Pathol 7 4280 -5
0

Citations

0

Downloads

72

Views